title: Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia.
authors.forename: Hang
authors.initials: H
authors.lastname: Quach
authors.forename: Lai-Yang
authors.initials: LY
authors.lastname: Lee
authors.forename: Brodie
authors.initials: B
authors.lastname: Smith
authors.forename: Tony
authors.initials: T
authors.lastname: Korman
authors.forename: Ian J
authors.initials: IJ
authors.lastname: Woolley
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D001565:Benzoates / Q000008:administration & dosage / Q000494:pharmacology*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004338:Drug Combinations; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology*; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D010078:Oxazines / Q000008:administration & dosage / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D001565:Benzoates; D004338:Drug Combinations; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D006834:Hydrazines; D063065:Organophosphonates; D010078:Oxazines; D011720:Pyrazoles; D018894:Reverse Transcriptase Inhibitors; D003841:Deoxycytidine; D000225:Adenine; C520809:eltrombopag